发明名称 |
USE OF GRF-1 (1-29 ) AND CORTICOTROPIN-RELEASING FACTOR AS THERAPEUTIC AGENTS |
摘要 |
The present invention is directed to the use of the combination of the Tyr-Ala-Asp-Ala-lle-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-lle-Met-Ser-Arg-NH2 and Ser-Glu-Glu-Pro-Pro-lle-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-lle-lle-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease. |
申请公布号 |
WO2009043520(A1) |
申请公布日期 |
2009.04.09 |
申请号 |
WO2008EP08102 |
申请日期 |
2008.09.09 |
申请人 |
MONDOBIOTECH LABORATORIES AG;BEVEC, DORIAN;CAVALLI, FABIO;CAVALLI, VERA;BACHER, GERALD |
发明人 |
BEVEC, DORIAN;CAVALLI, FABIO;CAVALLI, VERA;BACHER, GERALD |
分类号 |
A61K38/22;A61K38/25;A61P3/00;A61P9/00;A61P11/00;A61P25/28;A61P31/00;A61P31/20;A61P35/00;A61P37/00 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|